Skip to main content
Erschienen in: Clinical Oral Investigations 8/2020

12.11.2019 | Original Article

In vitro and in silico evaluations of resin-based dental restorative material toxicity

verfasst von: Susana Bandarra, Paulo Mascarenhas, Ana R. Luís, Mafalda Catrau, Evguenia Bekman, Ana C. Ribeiro, Sérgio Félix, Jorge Caldeira, Isabel Barahona

Erschienen in: Clinical Oral Investigations | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Objectives

This study aims to evaluate the cytocompatibility of three provisional restoration materials and predict neurotoxic potential of their monomers. These materials are Tab 2000® (methyl methacrylate based), ProTemp 4™ (bis-acrylic based) and Structur 3® (urethane dimethacrylate based).

Materials and methods

Resin samples were incubated in a cell culture medium and the cytotoxic effects of these extracts were studied in 3T3 fibroblast cells through MTT and crystal violet assays as well as ROS assessment. The presence of relevant leached monomers was determined by HPLC. Additionally, the blood-brain barrier (BBB) permeability to these resin-based monomers was predicted using ACD/Labs algorithms model.

Results

Cell survival rates were compared with the resin extracts, and Structur 3® was statistically significant different from the others (p < 0.001) at all-time incubation periods. All materials induced a dose-dependent loss of cell viability; however, only Structur 3 extracts were cytotoxic against 3T3 fibroblasts. The highest cytotoxic effect (77%, p < 0.001) was observed at 24 h incubation period, which may be associated with the presence of urethane dimethacrylate (UDMA) leached monomers. Furthermore, the computational model showed that most monomers under study are expectedly capable of crossing the BBB.

Conclusions

Our results showed that Structur 3® is not cytocompatible with our cell model and UDMA is a potential neurotoxic compound.

Clinical relevance

These results indicate that only ProTemp 4™ and Tab 2000® are safe for provisional restorations.
Literatur
4.
Zurück zum Zitat Zabrovsky A, Beyth N, Pietrokovski Y, et al (2017) 5 – Biocompatibility and functionality of dental restorative materials. In: Shelton R (ed) Biocompatibility of dental biomaterials. Woodhead Publishing Series in Biomaterials, pp 63–75 Zabrovsky A, Beyth N, Pietrokovski Y, et al (2017) 5 – Biocompatibility and functionality of dental restorative materials. In: Shelton R (ed) Biocompatibility of dental biomaterials. Woodhead Publishing Series in Biomaterials, pp 63–75
15.
Zurück zum Zitat Ulker M, Ulker HE, Zortuk M, Bulbul M, Tuncdemir AR, Bilgin MS (2009) Effects of current provisional restoration materials on the viability of fibroblasts. Eur J Dent 3:114–119CrossRef Ulker M, Ulker HE, Zortuk M, Bulbul M, Tuncdemir AR, Bilgin MS (2009) Effects of current provisional restoration materials on the viability of fibroblasts. Eur J Dent 3:114–119CrossRef
16.
Zurück zum Zitat Ergün G, Mutlu-Sagesen L, Karaoglu T, Dogan A (2001) Cytotoxicity of provisional crown and bridge restoration materials: an in vitro study. J Oral Sci 43:123–128CrossRef Ergün G, Mutlu-Sagesen L, Karaoglu T, Dogan A (2001) Cytotoxicity of provisional crown and bridge restoration materials: an in vitro study. J Oral Sci 43:123–128CrossRef
18.
Zurück zum Zitat ISO 10993-5 (2009) Biological evaluation of medical devices - part 5: tests for in vitro cytotoxicity. International Organization for Standardization, Geneva ISO 10993-5 (2009) Biological evaluation of medical devices - part 5: tests for in vitro cytotoxicity. International Organization for Standardization, Geneva
19.
Zurück zum Zitat ISO 7405 (2018) Dentistry - Evaluation of biocompatibility of medical devices used in dentistry. International Organization for Standardization, Geneva ISO 7405 (2018) Dentistry - Evaluation of biocompatibility of medical devices used in dentistry. International Organization for Standardization, Geneva
Metadaten
Titel
In vitro and in silico evaluations of resin-based dental restorative material toxicity
verfasst von
Susana Bandarra
Paulo Mascarenhas
Ana R. Luís
Mafalda Catrau
Evguenia Bekman
Ana C. Ribeiro
Sérgio Félix
Jorge Caldeira
Isabel Barahona
Publikationsdatum
12.11.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Oral Investigations / Ausgabe 8/2020
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-019-03131-4

Weitere Artikel der Ausgabe 8/2020

Clinical Oral Investigations 8/2020 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.